76 related articles for article (PubMed ID: 16806917)
1. Newly discovered orally active pure antiestrogens.
Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Yoneya T; Ohizumi I; Tsunenari T; Taniguchi K; Kaiho S; Nabuchi Y; Araya H; Kawata S; Morikawa K; Jo JC; Kwon HA; Lim HS; Kim HY
Bioorg Med Chem Lett; 2006 Sep; 16(18):4959-64. PubMed ID: 16806917
[TBL] [Abstract][Full Text] [Related]
2. Discovery of thiochroman derivatives bearing a carboxy-containing side chain as orally active pure antiestrogens.
Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Tsunenari T; Taniguchi K; Ohizumi I; Kaiho S; Nabuchi Y; Kawata S; Morikawa K; Jo JC; Kwon HA; Lim HS; Kim HY
Bioorg Med Chem Lett; 2006 Aug; 16(15):4090-4. PubMed ID: 16709454
[TBL] [Abstract][Full Text] [Related]
3. Discovery of thiochroman and chroman derivatives as pure antiestrogens and their structure-activity relationship.
Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Kato N; Tsunenari T; Taniguchi K; Ohizumi I; Kaiho S; Morikawa K; Jo JC; Lim HS; Kim HY
Bioorg Med Chem; 2006 Jul; 14(14):4803-19. PubMed ID: 16580210
[TBL] [Abstract][Full Text] [Related]
4. Discovery and structure-activity relationships of new steroidal compounds bearing a carboxy-terminal side chain as androgen receptor pure antagonists.
Tachibana K; Imaoka I; Yoshino H; Kato N; Nakamura M; Ohta M; Kawata H; Taniguchi K; Ishikura N; Nagamuta M; Onuma E; Sato H
Bioorg Med Chem Lett; 2007 Oct; 17(20):5573-6. PubMed ID: 17804229
[TBL] [Abstract][Full Text] [Related]
5. Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor.
Lloyd DG; Hughes RB; Zisterer DM; Williams DC; Fattorusso C; Catalanotti B; Campiani G; Meegan MJ
J Med Chem; 2004 Nov; 47(23):5612-5. PubMed ID: 15509159
[TBL] [Abstract][Full Text] [Related]
6. Characterization of molecular and structural determinants of selective estrogen receptor downregulators.
Fan M; Rickert EL; Chen L; Aftab SA; Nephew KP; Weatherman RV
Breast Cancer Res Treat; 2007 May; 103(1):37-44. PubMed ID: 17033922
[TBL] [Abstract][Full Text] [Related]
7. Antiestrogenic activities of 3,8-dihydroxy-6,11-dihydrobenzo[a]carbazoles with sulfur-containing side chains.
Golob T; Biberger C; Walter G; von Angerer E
Arch Pharm (Weinheim); 2000 Sep; 333(9):305-11. PubMed ID: 11039187
[TBL] [Abstract][Full Text] [Related]
8. Insight from molecular modeling into different conformation and SAR of natural steroids and unnatural 7-oxa-steroids.
Kang FA; Chen X; Jain N; Allan G; Tannenbaum P; Lundeen S; Sui Z
Bioorg Med Chem Lett; 2008 Jul; 18(13):3687-90. PubMed ID: 18539027
[TBL] [Abstract][Full Text] [Related]
9. Enaminone amides as novel orally active GABAA receptor modulators.
Hogenkamp DJ; Johnstone TB; Huang JC; Li WY; Tran M; Whittemore ER; Bagnera RE; Gee KW
J Med Chem; 2007 Jul; 50(14):3369-79. PubMed ID: 17571865
[TBL] [Abstract][Full Text] [Related]
10. A novel carborane analog, BE360, with a carbon-containing polyhedral boron-cluster is a new selective estrogen receptor modulator for bone.
Hirata M; Inada M; Matsumoto C; Takita M; Ogawa T; Endo Y; Miyaura C
Biochem Biophys Res Commun; 2009 Mar; 380(2):218-22. PubMed ID: 19159615
[TBL] [Abstract][Full Text] [Related]
11. 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.
Zhang P; Terefenko E; Kern J; Fensome A; Trybulski E; Unwalla R; Wrobel J; Lockhead S; Zhu Y; Cohen J; Lacava M; Winneker RC; Zhang Z
Bioorg Med Chem; 2007 Oct; 15(20):6556-64. PubMed ID: 17681796
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors.
Weiss MM; Harmange JC; Polverino AJ; Bauer D; Berry L; Berry V; Borg G; Bready J; Chen D; Choquette D; Coxon A; DeMelfi T; Doerr N; Estrada J; Flynn J; Graceffa RF; Harriman SP; Kaufman S; La DS; Long A; Neervannan S; Patel VF; Potashman M; Regal K; Roveto PM; Schrag ML; Starnes C; Tasker A; Teffera Y; Whittington DA; Zanon R
J Med Chem; 2008 Mar; 51(6):1668-80. PubMed ID: 18324759
[TBL] [Abstract][Full Text] [Related]
13. Clusterin: a potential target for improving response to antiestrogens.
Toffanin S; Daidone MG; Miodini P; De Cecco L; Gandellini P; Cappelletti V
Int J Oncol; 2008 Oct; 33(4):791-8. PubMed ID: 18813793
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists.
Lai G; Merritt JR; He Z; Feng D; Chao J; Czarniecki MF; Rokosz LL; Stauffer TM; Rindgen D; Taveras AG
Bioorg Med Chem Lett; 2008 Mar; 18(6):1864-8. PubMed ID: 18304809
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis.
Salvo VA; Boué SM; Fonseca JP; Elliott S; Corbitt C; Collins-Burow BM; Curiel TJ; Srivastav SK; Shih BY; Carter-Wientjes C; Wood CE; Erhardt PW; Beckman BS; McLachlan JA; Cleveland TE; Burow ME
Clin Cancer Res; 2006 Dec; 12(23):7159-64. PubMed ID: 17145841
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel orally active ureido NPY Y5 receptor antagonists.
Li G; Stamford AW; Huang Y; Cheng KC; Cook J; Farley C; Gao J; Ghibaudi L; Greenlee WJ; Guzzi M; van Heek M; Hwa JJ; Kelly J; Mullins D; Parker EM; Wainhaus S; Zhang X
Bioorg Med Chem Lett; 2008 Feb; 18(3):1146-50. PubMed ID: 18160282
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, biological evaluation and pharmacokinetics of bis(hydroxyphenyl) substituted azoles, thiophenes, benzenes, and aza-benzenes as potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1).
Bey E; Marchais-Oberwinkler S; Werth R; Negri M; Al-Soud YA; Kruchten P; Oster A; Frotscher M; Birk B; Hartmann RW
J Med Chem; 2008 Nov; 51(21):6725-39. PubMed ID: 18855374
[TBL] [Abstract][Full Text] [Related]
18. Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists.
Washburn DG; Hoang TH; Frazee JS; Johnson L; Hammond M; Manns S; Madauss KP; Williams SP; Duraiswami C; Tran TB; Stewart EL; Grygielko ET; Glace LE; Trizna W; Nagilla R; Bray JD; Thompson SK
Bioorg Med Chem Lett; 2009 Aug; 19(16):4664-8. PubMed ID: 19616429
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists.
Chen C; Tucci FC; Jiang W; Tran JA; Fleck BA; Hoare SR; Wen J; Chen T; Johns M; Markison S; Foster AC; Marinkovic D; Chen CW; Arellano M; Harman J; Saunders J; Bozigian H; Marks D
Bioorg Med Chem; 2008 May; 16(10):5606-18. PubMed ID: 18417348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
